EichorEICHOR
Location: Bergen Synced from ClinicalTrials.gov · August 08, 2026

Clinical studies recruiting near Bergen

Studies with at least one listed site matching this location on the public registry. Each page explains the study in plain language, with locations and study-team contacts. Clinicians: generate a printable list for your patient →

A Study of Ruxolitinib for Preventing Graft-Versus-Host Disease in People With a Hematologic Malignancy Who Will Receive
Phase 2 · Memorial Sloan Kettering Cancer Center · NCT07359859A Study of Nipocalimab in Reducing the Risk of Fetal and Neonatal Alloimmune Thrombocytopenia (FNAIT)
Phase 3 · Haukeland University Hospital · Janssen Research & Development, LLC · NCT06449651Observational Study Protocol: LIVER-R
Phase N/A · Research Site · AstraZeneca · NCT06252753Enhanced Pain Coping in Cancer (EPIC): A Study of Managing Treatment-Related Joint Pain in Breast Cancer Survivors
Phase 2 · Memorial Sloan Kettering Cancer Center · NCT06728579This Study Will Explore Whether a Combination of the Investigational Drug Mevrometostat (PF-06821497) and Enzalutamide W
Phase 3 · Pfizer · NCT07028853Interfant-21 Treatment Protocol for Infants Under 1 Year With KMT2A-rearranged ALL or Mixed Phenotype Acute Leukemia
Phase 3 · Haukeland University Hospital · Princess Maxima Center for Pediatric Oncology · NCT05327894MYELOMATCH: A Screening Study to Assign People With Myeloid Cancer to a Treatment Study or Standard of Care Treatment Wi
Phase 2 · National Cancer Institute (NCI) · NCT05564390Testing the Addition of High Dose, Targeted Radiation to the Usual Treatment for Locally-Advanced Inoperable Non-Small C
Phase 3 · NRG Oncology · NCT05624996Endoscopic Ultrasound-guided Radiofrequency Ablation in Primary Aldosteronism
NA · Haukeland University Hospital · Haukeland University Hospital · NCT05368090A Study to Learn About the Study Medicine PF-08052667 in People With Bladder Cancer
Phase 1 · Pfizer · NCT07206225Lomustine in Addition to Standard of Care in Patients With MGMT Methylated Glioblastoma
Phase 3 · Haukeland University Hospital · Vastra Gotaland Region · NCT06419946A Study on Adding Precisely Targeted Radiation Therapy (Stereotactic Body Radiation Therapy) to the Usual Treatment Appr
Phase 2 · Memorial Sloan Kettering Cancer Center · NCT05534438A Study of Tucatinib and Trastuzumab in People With Rectal Cancer
Phase 2 · Memorial Sloan Kettering Cancer Center · NCT05672524Assessment of Short Immunotherapy After Radical Surgery of High-risk Malignant Melanoma
Phase 3 · Haukeland University Hospital · Uppsala University · NCT06488482A Study of Mesothelin-Targeted CAR T-Cell Therapy in People With Esophagogastric Cancer
Phase 1 · Memorial Sloan Kettering Cancer Center · NCT06623396A Study Evaluating the Efficacy and Safety of Divarasib and Pembrolizumab Versus Pembrolizumab and Pemetrexed and Carbop
Phase 3 · Hoffmann-La Roche · NCT06793215Effects of Proactive Call to Customers of Norsk Rikstoto (Horse Gambling Operator in Norway): A Randomized Controlled St
NA · University of Bergen, Department of Psychosocial Science · University of Bergen · NCT07028450A Study of Fianlimab, Cemiplimab, and Ipilimumab in People With Melanoma
Phase 2 · Memorial Sloan Kettering Cancer Center · NCT06594991A Study of Valemetostat in Combination With Atezolizumab in People With Lung Cancer
Phase 1 · Memorial Sloan Kettering Cancer Center · NCT06807632A Study on the Effects of Exercise Therapy on Signs of Prostate Cancer
Phase 2 · City of Hope Medical Center · NCT05751434A Study of Natural Killer Cells in Combination With Atezolizumab in People With Acute Myelogenous Leukemia
Phase 1 · Memorial Sloan Kettering Cancer Center · NCT07011004Cabozantinib in Patients With RET Fusion-Positive Advanced Non-Small Cell Lung Cancer and Those With Other Genotypes: RO
Phase 2 · Memorial Sloan Kettering Cancer Center · NCT01639508A Study of Pirtobrutinib, Venetoclax, and Rituximab in People With Waldenström's Macroglobulinemia (WM)/Lymphoplasmacyti
Phase 2 · Memorial Sloan Kettering Cancer Center · NCT07231952A Study Collecting Health Information to Understand and Prevent Gastric Cancer
Phase N/A · Memorial Sloan Kettering Cancer Center · NCT06370143An Intervention to Increase Genetic Testing in Families Who May Share a Gene Mutation Related to Cancer Risk and An Inte
NA · Memorial Sloan Kettering Cancer Center · NCT05420064A Trial of Nicotinamide/Pterostilbene Supplement in ALS: The NO-ALS Extension Study
NA · Haukeland University Hospital · Haukeland University Hospital · NCT05095571A Study of Azacitidine and Venetoclax in People With Acute Myeloid Leukemia (AML)
Phase 2 · Memorial Sloan Kettering Cancer Center · NCT06773208A Study of Bempedoic Acid in Combination With Ezetimibe and Either Rosuvastatin or Atorvastatin in Patients With Primary
Phase N/A · Daiichi Sankyo Europe, GmbH, a Daiichi Sankyo Company · NCT06686615Study of Olomorasib (LY3537982) in Combination With Standard of Care in Participants With Resected or Unresectable KRAS
Phase 3 · Haukeland Universitetssjukehus · Eli Lilly and Company · NCT06890598Bortezomib and Temozolomide in Recurrent Grade-4 Glioma Unmethylated MGMT Promoter (BORTEM-17)
Phase 1/Phase 2 · Haukeland University Hospital · Haukeland University Hospital · NCT03643549
Look up another city
Look up another condition
Eichor
Clinical intelligence from public evidence
Use of Eichor is governed by our Terms of Use · Privacy Policy
© 2026 Biomedistats LLC (dba Eichor)

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.